182 related articles for article (PubMed ID: 35784727)
21. Utilization, Cost, and Affordability of Antihypertensive Therapy in Bulgaria.
Mitkova Z; Petrova G
Iran J Pharm Res; 2021; 20(2):403-416. PubMed ID: 34567170
[TBL] [Abstract][Full Text] [Related]
22. Trends in antihypertensives use among Moroccan patients.
Berrada El Azizi G; Ahid S; Ghanname I; Belaiche A; Hassar M; Cherrah Y
Pharmacoepidemiol Drug Saf; 2012 Oct; 21(10):1067-73. PubMed ID: 22585420
[TBL] [Abstract][Full Text] [Related]
23. Long-term drug use and polypharmacy among the elderly population in the Republic of Srpska, Bosnia and Herzegovina.
Marković-Peković V; Škrbić R
Vojnosanit Pregl; 2016 May; 73(5):435-41. PubMed ID: 27430107
[TBL] [Abstract][Full Text] [Related]
24. Trends in the utilization of antihypertensive medications among Palestine refugees in Jordan, 2008-2012.
Saadeh R; Qato D; Khader A; Shahin Y; Seita A
J Pharm Policy Pract; 2015; 8(1):17. PubMed ID: 25992295
[TBL] [Abstract][Full Text] [Related]
25. Utilization of psychotropic medicines in Romania during 1998-2018.
Iaru I; Bucsa C; Farcas A; Pop C; Cristina A; Armean S; Brumboiu I; Vostinaru O; Mogosan C
Front Pharmacol; 2023; 14():1157231. PubMed ID: 37050903
[No Abstract] [Full Text] [Related]
26. [Analysis of prescription and rationality of anti-hypertensive medication among community health centers in Beijing].
Bai JJ; Zhang WL; Wang L; Liu PY; Cai J
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Oct; 49(10):993-999. PubMed ID: 34674437
[No Abstract] [Full Text] [Related]
27. Outpatient use of systemic antibiotics in croatia.
Stimac D; Vukusić I; Culig J
Pharm World Sci; 2005 Jun; 27(3):230-5. PubMed ID: 16096893
[TBL] [Abstract][Full Text] [Related]
28. Patterns in anticoagulant utilization in the Czech Republic during 2007-2017.
Maly J; Dvorackova S; Zimcikova E; Kubena AA; Kolar J; Vlcek J; Penka M; Mala-Ladova K
J Thromb Thrombolysis; 2019 Feb; 47(2):305-311. PubMed ID: 30659407
[TBL] [Abstract][Full Text] [Related]
29. [Antihypertensive pharmacotherapy of patients in primary care with either a statutory or private health insurance].
Laux G; Szecsenyi J; Miksch A; Grün B; Gutscher A; Grün B; Rosemann T; Kühlein T
Med Klin (Munich); 2009 Feb; 104(2):108-13. PubMed ID: 19242661
[TBL] [Abstract][Full Text] [Related]
30. Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes?
Grimmsmann T; Himmel W
Eur J Clin Pharmacol; 2011 Aug; 67(8):847-54. PubMed ID: 21544512
[TBL] [Abstract][Full Text] [Related]
31. Advertising of antihypertensive medicines and prescription sales in Australia.
Vitry A; Lai YH
Intern Med J; 2009 Nov; 39(11):728-32. PubMed ID: 19226422
[TBL] [Abstract][Full Text] [Related]
32. Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study.
Rouette J; McDonald EG; Schuster T; Brophy JM; Azoulay L
BMJ Open; 2022 Jun; 12(6):e057510. PubMed ID: 35688595
[TBL] [Abstract][Full Text] [Related]
33. Drug utilization 90%--a simple method for assessing the quality of drug prescribing.
Bergman U; Popa C; Tomson Y; Wettermark B; Einarson TR; Aberg H; Sjöqvist F
Eur J Clin Pharmacol; 1998 Apr; 54(2):113-8. PubMed ID: 9626914
[TBL] [Abstract][Full Text] [Related]
34. Pattern analysis and variations in the utilization of antihypertensive drugs in Taiwan: a six-year study.
Huang LY; Shau WY; Chen HC; Su S; Yang MC; Yeh HL; Lai MS
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):410-9. PubMed ID: 23426547
[TBL] [Abstract][Full Text] [Related]
35. Trends and patterns of five antihypertensive drug classes between 2007 and 2012 in China using hospital prescription data.
Xu H; He Y; Xu L; Yan X; Dai H
Int J Clin Pharmacol Ther; 2015 Jun; 53(6):430-7. PubMed ID: 25828638
[TBL] [Abstract][Full Text] [Related]
36. Quality of cardiovascular drugs prescribing in Croatia 2003-2008.
Stimac D
Coll Antropol; 2012 Jan; 36 Suppl 1():189-94. PubMed ID: 22338770
[TBL] [Abstract][Full Text] [Related]
37. Impact of the World Health Organization Pain Treatment Guidelines and the European Medicines Agency Safety Recommendations on Nonsteroidal Anti-Inflammatory Drug Use in Lithuania: An Observational Study.
Kasciuškevičiūtė S; Gumbrevičius G; Vendzelytė A; Ščiupokas A; Petrikonis K; Kaduševičius E
Medicina (Kaunas); 2018 May; 54(2):. PubMed ID: 30344261
[No Abstract] [Full Text] [Related]
38. Wealth-related Inequality in Utilization of Antihypertensive Medicines in Iran: an Ecological Study on Population Level Data.
Hashemi-Meshkini A; Kebriaeezadeh A; Jamshidi H; Akbari-Sari A; Rezaei-Darzi E; Mehdipour P; Nikfar S; Farzadfar F
Arch Iran Med; 2016 Feb; 19(2):116-22. PubMed ID: 26838082
[TBL] [Abstract][Full Text] [Related]
39. The outpatient utilization of non-steroidal anti-inflammatory drugs in South Bačka District, Serbia.
Calasan J; Mijatović V; Horvat O; Varga J; Sabo A; Stilinović N
Int J Clin Pharm; 2011 Apr; 33(2):246-51. PubMed ID: 21744192
[TBL] [Abstract][Full Text] [Related]
40. [Use of antihypertensive drugs in Spain, 1985-1995].
Prieto M; de Abajo FJ; Montero D; Martín-Serrano G; Madurga M; Palop R
Med Clin (Barc); 1998 Feb; 110(7):247-53. PubMed ID: 9562948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
